Skip to main content
QDEL logo

QDEL · QuidelOrtho Corp

Track QDEL — free
Market Cap
$958.00M
Shares
68.58M

QDEL metrics

71 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.97
Market cap
$958.00M

Price action

19 metrics
Price change (1W)
-5.2%
Price change (30D)
+13.7%
Price change (3M)
-2.5%
Price change (6M)
-32.9%
Price change (YTD)
-51.1%
Price change (1Y)
-49.7%
Trailing year
Price change (5Y)
-90.2%
52-week high
$35.38
52-week low
$9.96
Change from 52-week high
-60.5%
Change from 52-week low
+40.3%
Annualized volatility
89.4%
Beta
2.4
RSI (14D)
43.3
Price vs SMA 50
-12.5%
Price vs SMA 200
-28.2%
Avg volume (3M)
1.52M
Relative volume
0.6
Average dollar volume
$23.33M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
68.58M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.4×
reciprocal yield 279.1%
P / book
0.5
reciprocal yield 185.3%
FCF yield
-22.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
P / operating cash flow
Earnings yield
-109.4%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
1.7×
reciprocal yield 58.4%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.8%
EV / EBIT historical average (3Y)
27.3×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
27.3×
reciprocal yield 3.7%
EV / EBITDA historical average (3Y)
12.0×
reciprocal yield 8.4%
EV / EBITDA historical average (5Y)
12.0×
reciprocal yield 8.4%

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
0.0%
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
Operating margin
-30.8%
Trailing 12 months
Net margin
-39.2%
Gross profit (TTM)
Operating profit (TTM)
−$824.70M
Net income (TTM)
−$1.05B
Trailing 12 months
Diluted EPS (TTM)
$-15.44
FCF margin
-7.9%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$46.27

Growth

11 metrics
Revenue growth YoY
+2.8%
Year over year
Net income growth YoY
Revenue (TTM)
$2.67B
Trailing 12 months
EPS growth YoY
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
-5.8%
Revenue CAGR (5Y)
+10.4%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-59.1%
Return on assets
-18.3%
Debt / equity
Current ratio
1.4
EBITDA (TTM)
−$370.50M
Free cash flow (TTM)
−$211.20M
Quick ratio
0.8
Interest coverage
-4.1
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$123.40M
Total assets
$5.72B
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$57.20M
Capital expenditures (TTM)
$154.00M
R&D (TTM)
$180.90M
SG&A (TTM)
$770.30M
Stock compensation (TTM)
$44.20M
R&D / revenue
6.8%
Stock compensation / revenue
1.7%

Ownership (13F)

3 metrics
13F filers
249
13F filer change QoQ
+7
Institutional ownership
122.0%

Short interest

3 metrics
Short interest
21.8%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 1906324 CUSIP 219798105 13F (30d) 152 filings 152 filers Visit website Investor relations